当前位置: X-MOL 学术Autoimmun. Rev. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Worldwide trends in all-cause mortality of auto-immune systemic diseases between 2001 and 2014.
Autoimmunity Reviews ( IF 9.2 ) Pub Date : 2020-03-29 , DOI: 10.1016/j.autrev.2020.102531
Marc Scherlinger 1 , Philippe Mertz 2 , Flora Sagez 2 , Alain Meyer 2 , Renaud Felten 2 , Emmanuel Chatelus 2 , Rose-Marie Javier 2 , Christelle Sordet 2 , Thierry Martin 3 , Anne-Sophie Korganow 3 , Aurélien Guffroy 3 , Vincent Poindron 4 , Christophe Richez 1 , Marie-Elise Truchetet 1 , Patrick Blanco 5 , Thierry Schaeverbeke 6 , Jean Sibilia 5 , Hervé Devillers 7 , Laurent Arnaud 8
Affiliation  

AIM To describe changes in the 2001-2014 mortality of 6 autoimmune systemic diseases (AISDs), namely Systemic Lupus Erythematosus (SLE), Systemic Sclerosis (SSc), Idiopathic Inflammatory Myopathies (IIM), Sjögren's Syndrome (SS), Mixed Connective Tissue Disease (MCTD) and ANCA-associated vasculitis (AAV) at the country-, continent-, and world-levels. METHODS Mortality data were retrieved from the World Health Organization (WHO) mortality database for each disease, based on ICD-10 codes. We computed age-standardized mortality rate (ASMR) as the estimated number of deaths per million inhabitants and its 95% confidence interval (95%CI). The association between gender, geographical areas and disease-specific mortality was analyzed using multivariate Poisson regression. The 2001-2014 temporal trends were analyzed using Jointpoint software. RESULTS In 2014, the worldwide ASMR for SLE was 2.68 (95%CI: 2.62-2.75) deaths/millions inhabitants, 1.46 (1.42-1.51) for SSc, 0.47 (0.44-0.49) for IIM, 0.17 (0.15-0.18) for SS, 0.11 (0.10-0.13) for MCTD and 0.53 (0.50-0.56) for AAV, with ASMRs generally lower in Europe than in North America, Latin America and Asia. Between 2001 and 2014, the worldwide ASMR decreased significantly for SSc (-0.71%/year), IIM (-1.65%/year) and AAV (-1.01%/year; p < .001 for all) and increased for SS (+1.53%/year, p = .01). The worldwide ASMR of SLE decreased significantly between 2001 and 2003 (-6.37%, p < .05) before increasing slightly between 2004 and 2014 (+0.58%, p < .01). CONCLUSIONS We observed a strong heterogeneity of standardized mortality rates across all countries analyzed for 6 autoimmune diseases. Those results further highlight the impact of world-wide inequities and major gaps in access to care and strategies for diagnosis and management of rare diseases, a crucial finding for world-wide physicians, patient associations and policy makers.

中文翻译:

2001年至2014年间全球自身免疫性系统疾病全因死亡率的趋势。

目的描述6种自身免疫性系统疾病(AISD)在2001-2014年死亡率的变化,即系统性红斑狼疮(SLE),系统性硬化症(SSc),特发性炎症性肌病(IIM),干燥综合征(SS),混合性结缔组织病(MCTD)和与ANCA相关的血管炎(AAV)在国家,大陆和世界范围内。方法基于ICD-10代码,从世界卫生组织(WHO)死亡率数据库中检索出每种疾病的死亡率数据。我们将年龄标准化死亡率(ASMR)计算为每百万居民的估计死亡人数及其95%的置信区间(95%CI)。使用多元Poisson回归分析了性别,地理区域和特定疾病死亡率之间的关联。使用Jointpoint软件分析了2001-2014年的时间趋势。结果2014年,全球SLE的ASMR死亡/百万居民为2.68(95%CI:2.62-2.75),SSc为1.46(1.42-1.51),IIM为0.47(0.44-0.49),0.17(0.15-0.18) SS,MCTD为0.11(0.10-0.13),AAV为0.53(0.50-0.56),其中欧洲的ASMR通常低于北美,拉丁美洲和亚洲。在2001年至2014年之间,SSc(-0.71%/年),IIM(-1.65%/年)和AAV(-1.01%/年;所有p <0.001)的全球ASMR显着下降,而SS(+ 1.53%/年,p = 0.01)。SLE的全球ASMR在2001年至2003年期间显着下降(-6.37%,p <.05),然后在2004年至2014年之间略有上升(+ 0.58%,p <.01)。结论我们观察到在分析了6种自身免疫性疾病的所有国家中,标准化死亡率存在很大的异质性。
更新日期:2020-03-29
down
wechat
bug